AAAAAA

   
Results: 1-11 |
Results: 11
A WELL TOLERATED SCHEME FOR ADVANCED COLORECTAL-CANCER IN ELDERLY PATIENTS - BIMONTHLY CONTINOUS INFUSION FLUOROURACIL PLUS BOLUS AND HIGH-DOSE LEUCOVORIN
Authors: MATTIOLI R IMPERATORI L CASADEI V GUIDI F GATTAFONI P CONSALES D
Citation: R. Mattioli et al., A WELL TOLERATED SCHEME FOR ADVANCED COLORECTAL-CANCER IN ELDERLY PATIENTS - BIMONTHLY CONTINOUS INFUSION FLUOROURACIL PLUS BOLUS AND HIGH-DOSE LEUCOVORIN, Annals of oncology, 9, 1998, pp. 150-150
EFFICACY AND SAFETY OF VINORELBINE IN ELDERLY PATIENTS (AGED GREATER-THAN-70 YEARS) WITH ADVANCED NSCLC
Authors: CASADEI V MATTIOLI R IMPERATORI L GUIDI F GATTAFONI P PAGGI P LONARDO D CONSALES D
Citation: V. Casadei et al., EFFICACY AND SAFETY OF VINORELBINE IN ELDERLY PATIENTS (AGED GREATER-THAN-70 YEARS) WITH ADVANCED NSCLC, Annals of oncology, 9, 1998, pp. 151-151
A WELL TOLERATED SCHEME FOR ADVANCED COLORECTAL-CANCER IN ELDERLY PATIENTS - BIMONTHLY CONTINOUS INFUSION FLUOROURACIL PLUS BOLUS AND HIGH-DOSE LEUCOVORIN
Authors: MATTIOLI R IMPERATORI L CASADEI V
Citation: R. Mattioli et al., A WELL TOLERATED SCHEME FOR ADVANCED COLORECTAL-CANCER IN ELDERLY PATIENTS - BIMONTHLY CONTINOUS INFUSION FLUOROURACIL PLUS BOLUS AND HIGH-DOSE LEUCOVORIN, Annals of oncology, 9, 1998, pp. 71-71
PRELIMINARY EXPERIENCE - CHEMOTHERAPY WITH MITOXANTRONE AND VINBLASTINA IN ELDERLY WITH ADVANCED HORMONALLY RESISTANT PROSTATE-CANCER
Authors: MATTIOLI R IMPERATORI L CASADEI V
Citation: R. Mattioli et al., PRELIMINARY EXPERIENCE - CHEMOTHERAPY WITH MITOXANTRONE AND VINBLASTINA IN ELDERLY WITH ADVANCED HORMONALLY RESISTANT PROSTATE-CANCER, Annals of oncology, 9, 1998, pp. 122-122
THE IMPACT OF VINORELBINE IN ELDERLY (AGED GREATER-THAN-70 YEARS) WITH NSCLC - A PRELIMINARY-REPORT
Authors: MATTIOLI R IMPERATORI L CASADEI V FRAUSINI G GUIDI F GATTAFONI P PAGGI P LONARDO D CONSALES D
Citation: R. Mattioli et al., THE IMPACT OF VINORELBINE IN ELDERLY (AGED GREATER-THAN-70 YEARS) WITH NSCLC - A PRELIMINARY-REPORT, European journal of cancer, 33, 1997, pp. 1086-1086
IN-VITRO AND IN-VIVO CHARACTERIZATION OF LOW-RESISTANT MOUSE RETICULOSARCOMA (M5076) SUBLINES OBTAINED AFTER PULSE AND CONTINUOUS EXPOSURE TO CISPLATIN
Authors: BELVEDERE G IMPERATORI L DAMIA G TAGLIABUE G MEIJER C DEVRIES EGE DINCALCI M
Citation: G. Belvedere et al., IN-VITRO AND IN-VIVO CHARACTERIZATION OF LOW-RESISTANT MOUSE RETICULOSARCOMA (M5076) SUBLINES OBTAINED AFTER PULSE AND CONTINUOUS EXPOSURE TO CISPLATIN, European journal of cancer, 32A(11), 1996, pp. 2011-2018
SENSITIVITY OF CHO MUTANT-CELL LINES WITH SPECIFIC DEFECTS IN NUCLEOTIDE EXCISION-REPAIR TO DIFFERENT ANTICANCER AGENTS
Authors: DAMIA G IMPERATORI L STEFANINI M DINCALCI M
Citation: G. Damia et al., SENSITIVITY OF CHO MUTANT-CELL LINES WITH SPECIFIC DEFECTS IN NUCLEOTIDE EXCISION-REPAIR TO DIFFERENT ANTICANCER AGENTS, International journal of cancer, 66(6), 1996, pp. 779-783
3-METHYLADENINE-DNA-GLYCOSYLASE AND O-6-ALKYL GUANINE-DNA-ALKYLTRANSFERASE ACTIVITIES AND SENSITIVITY TO ALKYLATING-AGENTS IN HUMAN CANCER CELL-LINES
Authors: DAMIA G IMPERATORI L CITTI L MARIANI L DINCALCI MD
Citation: G. Damia et al., 3-METHYLADENINE-DNA-GLYCOSYLASE AND O-6-ALKYL GUANINE-DNA-ALKYLTRANSFERASE ACTIVITIES AND SENSITIVITY TO ALKYLATING-AGENTS IN HUMAN CANCER CELL-LINES, British Journal of Cancer, 73(7), 1996, pp. 861-865
CHANGES IN DOXORUBICIN DISTRIBUTION AND TOXICITY IN MICE PRETREATED WITH THE CYCLOSPORINE ANALOG SDZ-PSC-833
Authors: GONZALEZ O COLOMBO T DEFUSCO M IMPERATORI L ZUCCHETTI M DINCALCI M
Citation: O. Gonzalez et al., CHANGES IN DOXORUBICIN DISTRIBUTION AND TOXICITY IN MICE PRETREATED WITH THE CYCLOSPORINE ANALOG SDZ-PSC-833, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 335-340
3T3 NIH MURINE FIBROBLASTS AND B78 MURINE MELANOMA-CELLS EXPRESSING THE ESCHERICHIA-COLI N3-METHYLADENINE DNA GLYCOSYLASE-I DO NOT BECOME RESISTANT TO ALKYLATING-AGENTS
Authors: IMPERATORI L DAMIA G TAVERNA P GARATTINI E CITTI L BOLDRINI L DINCALCI M
Citation: L. Imperatori et al., 3T3 NIH MURINE FIBROBLASTS AND B78 MURINE MELANOMA-CELLS EXPRESSING THE ESCHERICHIA-COLI N3-METHYLADENINE DNA GLYCOSYLASE-I DO NOT BECOME RESISTANT TO ALKYLATING-AGENTS, Carcinogenesis, 15(3), 1994, pp. 533-537
IN-VIVO ANTITUMOR-ACTIVITY OF SYNTHETIC ETHER LIPIDS IS NOT ENHANCED BY PHARMACOLOGICAL MODULATION OF TUMOR LIPID-COMPOSITION
Authors: DIOMEDE L DAMIA G DINCALCI M IMPERATORI L ALGERI M MODEST EJ SALMONA M
Citation: L. Diomede et al., IN-VIVO ANTITUMOR-ACTIVITY OF SYNTHETIC ETHER LIPIDS IS NOT ENHANCED BY PHARMACOLOGICAL MODULATION OF TUMOR LIPID-COMPOSITION, International journal of cancer, 59(4), 1994, pp. 580-581
Risultati: 1-11 |